BRENDON CANT brendon at iinet.net.au
Tue Mar 31 04:57:01 CEST 2009

Crop Doctor 31/3/09

A new wheat variety promising big health benefits to consumers could be on
the market by 2013 thanks to research work partly funded by the Grains
Research and Development Corporation (GRDC).

It’s high amylose wheat and it promises a number of health benefits,
including better bowel health, preventing colorectal cancer and improving
control of blood glucose, which can help manage diabetes and reduce obesity.

High amylose wheat (HAW) contains a lot of resistant starch that is not
digested in the small intestine, passing instead to the large intestine,
where it’s broken down in the colon by bacteria.

GRDC Executive Manager, New Products, Vince Logan, said high amylose wheat
has been developed by Dr Matthew Morell and his team at CSIRO and by the
French company Biogemma over the last 10 years.

The team has already created HAW through genetic modification and
researchers were confident of breeding a conventional HAW using lessons from
genetic engineering.

It’s a novel initiative for the GRDC - one of the first wheat varieties it’s
been associated with that offers a consumer health benefit, rather than just
a production benefit.

Mr Logan thinks that while there’s a lot of interest in the product around
the world, it’s not yet clear how strong the demand for this novel wheat
will be.

To retain its value this specialist product will need to be segregated and
milled separately to maintain identity preservation. It will also need a
specialist marketing effort to promote its unique health benefits to food
manufacturers and consumers.

While many wheat breeders around the world have tried and failed to develop
similar products, Mr Logan believes the strong intellectual property
position of the Australian/French developers will put Australian growers in
the box seat to gain from the research.

The wheat is being produced by Arista Cereal Technologies Pty Ltd.,a joint
venture between the GRDC, the French company Limagrain Cereales Ingredients
and CSIRO’s Food Futures National Research Flagship.

There’s no doubt that if high amylose wheat is readily accepted by the
market it could make a significant contribution to community health. Some 80
per cent of deaths from colorectal cancer are preventable, with diet a major

High amylose wheat will add to the limited list of food products available
in Australia that have resistant starch. These include high amylose maize,
legumes, brown rice and bananas.

Western diets have lost a lot of the resistant starches that were in the
diet, with reduced consumption of whole grains, stone-ground flours and even
stale food, or food that’s been cooked, then cooled.

Food containing high amylose wheat promises to be an extremely convenient
way for people to enjoy the health benefits of resistant starch.


The Crop Doctor is GRDC Managing Director, Peter Reading, Tel 02 6166 4500
Further Information: Vince Logan, Tel 02 6166 4500


Brendon Cant & Associates
Public Relations & Marketing
Suite 5
4 Gugeri St
Claremont WA 6010
Tel 08 9384 1122

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.asc.asn.au/pipermail/asc-media/attachments/20090331/50ba028b/attachment.html>

More information about the ASC-media mailing list